Literature DB >> 23389377

Primary cardiac myxofibrosarcoma: a case report and review of the literature.

Ji-Gang Wang1, Yu-Jun Li, Hui Liu, Peng Zhao.   

Abstract

AIMS AND
BACKGROUND: Primary myxofibrosarcoma of the heart is a rare malignancy. To the best of our knowledge, no more than 17 cases have been reported since 1963. METHODS AND STUDY
DESIGN: We report the case of a 42-year-old man who presented with dyspnea and palpitation of one month's duration. Echocardiography and enhanced computed tomography revealed a large tumor in the left atrium.
RESULTS: The patient underwent palliative excision of the tumor and histopathological analysis revealed it to be a low-grade myxofibrosarcoma. The patient developed a bone metastasis two years later and is still alive 26 months after the cardiac surgery.
CONCLUSIONS: Primary cardiac myxofibrosarcoma involves predominantly the left atrium and the most common symptom induced by the tumor is dyspnea. Disease outcome is often disappointing despite aggressive postoperative radiotherapy and chemotherapy.

Entities:  

Mesh:

Year:  2012        PMID: 23389377     DOI: 10.1700/1217.13514

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


  4 in total

1.  A butterfly shaped mobile biatrial cardiac mass: myxoma or something else.

Authors:  Pallav Gupta; Aditya Kapoor; Manoj Jain; Sudeep Kumar; Surendra K Agarwal; Shantanu Pande
Journal:  Indian Heart J       Date:  2013-12-02

2.  Primary sarcoma of the heart: case report and literature review.

Authors:  Rieneke Moeri-Schimmel; Elisabeth Pras; Ingrid Desar; Stijn Krol; Pètra Braam
Journal:  J Cardiothorac Surg       Date:  2020-05-19       Impact factor: 1.637

3.  Low-grade myxofibrosarcoma following a metal implantation in femur: a case report.

Authors:  Weisong Li; Dan Li; Xiansen Zhu; Shaohui Lu; Chunlei He; Qingchun Yang
Journal:  Diagn Pathol       Date:  2014-01-20       Impact factor: 2.644

Review 4.  Primary cardiac myxofibrosarcoma: case report, literature review and pooled analysis.

Authors:  Dandan Sun; Yupeng Wu; Yan Liu; Jun Yang
Journal:  BMC Cancer       Date:  2018-05-02       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.